Bleakley Financial Group’s ImmunityBio IBRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-14,095
| Closed | -$36.1K | – | 722 |
|
|
2024
Q4 | $36.1K | Sell |
14,095
-1,848
| -12% | -$4.73K | ﹤0.01% | 1028 |
|
|
2024
Q3 | $59.3K | Buy |
15,943
+137
| +0.9% | +$510 | ﹤0.01% | 993 |
|
|
2024
Q2 | $99.9K | Buy |
15,806
+4,983
| +46% | +$31.5K | ﹤0.01% | 950 |
|
|
2024
Q1 | $58.1K | Buy |
+10,823
| New | +$58.1K | ﹤0.01% | 955 |
|